Feed Insights Top Reports Pricing

⌘K

16:06:49·6d

SECFilingvia Quantisnow

SEC Form DEF 14A filed by Veracyte Inc.

ByQuantisnow·Wall Street's wire, on your screen.

VCYT· Veracyte Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VCYT (Veracyte Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

VCYT
Veracyte Inc.
Health Care

Recent analyst ratings

Apr 13UpdateJefferies$45.00
Dec 2UpdateMorgan Stanley$48.00
Oct 20UpdateCanaccord Genuity$40.00
Mar 20UpdateCraig Hallum$45.00
Dec 5UpdateGoldman$37.00
Nov 15UpdateWolfe Research$50.00

Related

PR18h
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
SEC6d
SEC Form DEFA14A filed by Veracyte Inc.
INSIDER14d
SEC Form 4 filed by Haas Kevin Richard
PR14d
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026
ANALYST15d
Jefferies initiated coverage on Veracyte with a new price target
SEC32d
Amendment: SEC Form SCHEDULE 13G/A filed by Veracyte Inc.
INSIDER34d
SEC Form 3 filed by new insider Haas Kevin Richard
SEC43d
Veracyte Inc. filed SEC Form 8-K: Leadership Update

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022